Elevation Oncology, Inc. (ELEV)
NASDAQ: ELEV · Real-Time Price · USD
0.580
-0.046 (-7.30%)
At close: Dec 20, 2024, 4:00 PM
0.596
+0.016 (2.67%)
After-hours: Dec 20, 2024, 7:20 PM EST
Elevation Oncology Analyst Ratings
Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$7.20
Upside
+1,141.38%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
JMP Securities | JMP Securities | Buy Reiterates $7 | Buy | Reiterates | $7 | +1,106.90% | Dec 19, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +934.48% | Dec 13, 2024 |
Stephens & Co. | Stephens & Co. | Buy Reiterates $5 | Buy | Reiterates | $5 | +762.07% | Dec 6, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +934.48% | Aug 7, 2024 |
JMP Securities | JMP Securities | Buy Reiterates $7 | Buy | Reiterates | $7 | +1,106.90% | Jul 15, 2024 |
JMP Securities | JMP Securities | Buy Reiterates $7 | Buy | Reiterates | $7 | +1,106.90% | Jun 28, 2024 |
Piper Sandler | Piper Sandler | Buy Initiates $10 | Buy | Initiates | $10 | +1,624.14% | May 31, 2024 |
Stephens & Co. | Stephens & Co. | Buy Initiates $8 | Buy | Initiates | $8 | +1,279.31% | May 14, 2024 |
Wedbush | Wedbush | Buy Reiterates $8 | Buy | Reiterates | $8 | +1,279.31% | May 3, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +934.48% | Apr 9, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +934.48% | Mar 7, 2024 |
JMP Securities | JMP Securities | Buy Reiterates $7 | Buy | Reiterates | $7 | +1,106.90% | Mar 7, 2024 |
Wedbush | Wedbush | Buy Maintains $5 → $8 | Buy | Maintains | $5 → $8 | +1,279.31% | Mar 7, 2024 |
JMP Securities | JMP Securities | Buy Initiates $7 | Buy | Initiates | $7 | +1,106.90% | Mar 1, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $1.5 → $6 | Strong Buy | Maintains | $1.5 → $6 | +934.48% | Feb 20, 2024 |
Wedbush | Wedbush | Buy Reiterates $5 | Buy | Reiterates | $5 | +762.07% | Nov 6, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.